Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10721 (
c-kit
)
6,575
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have investigated the functional characteristics of peripheral blood-derived CD34+ cells mobilized by a combination of chemotherapy and G-CSF (mobilized peripheral blood-derived [
MPB
] CD34+ cells). In this study, subpopulations of
MPB
CD34+ cells have been directly compared in clonal cultures, long-term cultures with bone marrow (BM) stromal cells, and single-cell cultures.
MPB
CD34+ cells could be subdivided by expression levels of HLA-DR (DR), CD38, CD33 and
c-kit
antigens. The majority of
MPB
CD34+ cells expressed DR and CD38 antigens. In contrast, approximately 60% and 20% of the
MPB
CD34+ cells expressed CD33 and
c-kit
antigens, respectively. Interestingly,
MPB
CD34+ cells can be subdivided into three fractions which express high, low or negative levels of
c-kit
receptor. All types of committed progenitors were observed in populations of CD34+DR+, CD34+DR-, CD34+CD33-, CD34+CD38+ and CD34+
c-kit
(low) cells. Colony forming unit-granulocyte/macrophage was highly enriched in the population of CD34+CD33+ cells, whereas BFU-E was highly enriched in the population of CD34+
c-kit
(high) cells. In the population of CD34+CD38- cells, however, a few myeloid progenitors were detected. In addition, limiting dilution analyses clearly showed that the long-term culture-initiating cell (LTC-IC) is enriched in the populations of CD34+DR-, CD34+CD33- and CD34+c-kit-(or low) cells, but very few in CD34+
c-kit
(high) cells, and that CD38 antigen is not a useful marker for the enrichment of LTC-IC derived from
MPB
CD34+ cells. Moreover, single cell clone sorting experiments clearly demonstrated the functional differences between CD34+CD38+ and CD34+CD38- cells as well as CD34+ cells expressing different levels of
c-kit
receptor. Our results suggest that an immunophenotype of LTC-IC is different between BM-, cord blood- and
MPB
-derived CD34+ cells and that primitive and committed progenitors existing in these sources may be functionally different.
...
PMID:Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. 900 25